Literature DB >> 21791649

Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Thomas C Quinn.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21791649      PMCID： PMC3144171          DOI： 10.1093/infdis/jir317

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  48 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy.

Authors:  W Huang; V De Gruttola; M Fischl; S Hammer; D Richman; D Havlir; R Gulick; K Squires; J Mellors
Journal:  J Infect Dis       Date:  2001-04-24       Impact factor: 5.226

3.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

4.  Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults.

Authors:  Karen E Mark; Anna Wald; Amalia S Magaret; Stacy Selke; Steven Kuntz; Meei-Li Huang; Lawrence Corey
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

5.  Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-04-23       Impact factor: 17.586

6.  Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling.

Authors:  Catherine M Crespi; William G Cumberland; Anna Wald; Lawrence Corey; Sally Blower
Journal:  Sex Transm Infect       Date:  2007-05-02       Impact factor: 3.519

7.  Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Authors:  Sunitha Tata; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

Review 8.  Herpes simplex: insights on pathogenesis and possible vaccines.

Authors:  David M Koelle; Lawrence Corey
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

9.  Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.

Authors:  David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer
Journal:  J Infect Dis       Date:  2003-10-28       Impact factor: 5.226

10.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440
View more
  1 in total

1.  A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.

Authors:  Sita Awasthi; Gregory G Mahairas; Carolyn E Shaw; Meei-Li Huang; David M Koelle; Christine Posavad; Lawrence Corey; Harvey M Friedman
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.